Visual function
Ophthalmic teams document visual acuity and retinal findings before and after treatment.
Sudden loss of vision is an emergency. Call 911 or seek emergency care now; do not wait for a routine consultation.
Retinal artery occlusion research & care · Scottsdale & Glendale, AZ
For central retinal artery occlusion, early assessment can make a critical difference to the treatment options available.
RX-O2 offers a physician-led conversation about the evidence, your diagnosis, and the role of hyperbaric oxygen therapy in your broader care plan. Our Scottsdale and Glendale teams serve patients across the Phoenix area.
Research reports encouraging visual improvement in selected patients receiving early HBOT. Retinal artery occlusion is a time-sensitive emergency requiring immediate ophthalmic and stroke evaluation. Explore the evidence below.
Physician-led care in Scottsdale and Glendale, serving the Phoenix area.

The starting point
Central retinal artery occlusion, or CRAO, interrupts blood flow to the retina. Sudden painless loss of vision in one eye can be a warning sign that requires immediate emergency assessment.
HBOT increases dissolved oxygen and may help support threatened retinal tissue while the medical team evaluates the blockage and wider vascular risks. Suitability depends on timing, examination findings, and local emergency pathways.
The clinical context matters. Do not delay emergency or stroke evaluation to arrange a chamber appointment. HBOT, when considered, belongs within a coordinated emergency plan.
Connect the research to your goals
Ophthalmic teams document visual acuity and retinal findings before and after treatment.
Early presentation is a key factor in the available studies and in emergency decision-making.
Evaluation of the cause and future vascular risk remains essential even if vision improves.
Your goals help shape the conversation and provide a useful way to follow progress if treatment is prescribed.
Explore the evidence
Explore the findings behind the conversation. These selected publications highlight reported benefits, the patients studied, and the questions researchers are still working to answer.
Literature checked
October 20, 2026
2026 · Systematic review and meta-analysis
Publication indexed in PubMed. 2026.
Read the publicationA meta-analysis of 12 studies reported pooled findings favoring HBOT for visual outcomes in CRAO. Earlier treatment, particularly within 12 hours in the included analyses, was associated with greater improvement.
How to interpret it: Studies differed substantially and much of the evidence was observational. The review does not establish a guaranteed response or a universal time cutoff.
2017 · Retrospective clinical study
Hadanny A, et al. Clinical ophthalmology (Auckland, N.Z.). 12/29/2016.
Read the publicationA retrospective study of 128 selected patients treated within 20 hours of symptom onset reported visual improvement. Retinal examination findings were associated with response.
How to interpret it: There was no randomized untreated comparison, and the selected population limits generalization. Examination findings and rapid specialist assessment matter.
The visual recovery signal supports prompt specialist consideration in appropriately selected cases. Ongoing research is clarifying patient selection and the added benefit beyond other care. Your emergency team should direct immediate treatment and any hyperbaric referral.
Plan with your care team
An urgent referral should include the exact symptom-onset time, ophthalmic findings, visual acuity, and emergency or stroke-team assessment.
Review the evidence with your treating specialist and hyperbaric clinician. Identify specific outcomes to follow, the alternatives, and the reasons HBOT may or may not be appropriate.
If treatment is prescribed, discuss the schedule, travel, costs, safety screening, and how progress will be reviewed. A published study schedule does not determine an individual prescription.
Your consultation is an opportunity to ask about expected benefits, treatment experience, scheduling, costs, and follow-up. We review suitability with you and coordinate with your treating clinicians when appropriate.
The RX-O2 difference
Medical Director Marvin A. Borsand, DO, FACOS, FACCS, HCC, leads clinical oversight. A licensed medical provider reviews suitability and prescribes treatment when appropriate.
Our clinics use FDA-cleared hard-shell chambers. You breathe 100% medical oxygen through a mask or hood while the chamber is pressurized with air.
NHSA-certified hyperbaric technicians explain the visit and monitor treatment. Tell us about ear pressure, positioning, mobility, or confinement concerns before you arrive.
Before your visit
Seek emergency care immediately. Do not wait for an outpatient consultation or assume that painless vision loss can wait.
Some patients improve, but full recovery is not assured. Timing, retinal findings, and the underlying vascular problem influence the discussion.
No. Ophthalmic and stroke or vascular evaluation remain essential. A chamber treatment does not identify or address every cause of arterial blockage.
RX-O2 has clinics in Scottsdale and Glendale. Bring your records or ask your provider to send a referral so that the team can review your circumstances and explain whether an outpatient consultation is appropriate.
Local care, two Valley locations
Looking for a hyperbaric consultation near Phoenix? RX-O2 offers two locations for patients across the Valley. Call the clinic closest to you for appointment availability and help planning repeat visits.
An East Valley option for patients in Scottsdale, Paradise Valley, Fountain Hills, and nearby communities.
A West Valley option for patients in Glendale, Peoria, Phoenix, and nearby communities.
After urgent medical needs have been addressed, ask your treating team whether an outpatient hyperbaric consultation has a role.
Browse the complete HBOT research library · Learn how HBOT works
Selected research checked October 20, 2026. Evidence continues to evolve. This educational overview supports a conversation with your treating clinician; individual results vary.
Read HBOT safety and treatment FAQs. Discuss treatment risks, medicines, implants, and relevant medical history with your clinician. Equipment clearance does not establish effectiveness for every condition.